Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 1,358

The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.

Diabetic Retinopathy: Pathophysiology and Treatments

Open access
Wang, Wei, Lo, Amy C. Y. · 2018 · International Journal of Molecular Sciences

Abstract

Diabetic retinopathy (DR) is the most common complication of diabetes mellitus (DM). It has long been recognized as a microvascular disease. The diagnosis of DR relies on the detection of microvascular lesions. The treatment of DR remains challenging. The advent of anti-vascular endothelial growth factor (VEGF) therapy demonstrated remarkable clinical benefits in DR patients; however, the majority of patients failed to achieve clinically-significant visual improvement. Therefore, there is an urgent need for the development of new treatments. Laboratory and clinical evidence showed that in addition to microvascular changes, inflammation and retinal neurodegeneration may contribute to diabetic retinal damage in the early stages of DR. Further investigation of the underlying molecular mechanisms may provide targets for the development of new early interventions. Here, we present a review of the current understanding and new insights into pathophysiology in DR, as well as clinical treatments for DR patients. Recent laboratory findings and related clinical trials are also reviewed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms19061816

Cites

69 of 69 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 10

  1. Lupo, 2013, Role of phospholipases A2 in diabetic retinopathy: In vitro and in vivo studies, Biochem. Pharmacol., 86, 1603, 10.1016/j.bcp.2013.09.008 · doi:10.1016/j.bcp.2013.09.008
  2. Kasza, 2017, Plasma E-selectin levels can play a role in the development of diabetic retinopathy, Graefe’s Arch. Clin. Exp. Ophthalmol., 255, 25, 10.1007/s00417-016-3411-1 · doi:10.1007/s00417-016-3411-1
  3. Limb, 1999, Vascular adhesion molecules in vitreous from eyes with proliferative diabetic retinopathy, Investig. Ophthalmol. Vis. Sci., 40, 2453
  4. Sivkova, 2011, Serum inflammatory cytokines IL-1beta, IL-6, TNF-alpha and VEGF have influence on the development of diabetic retinopathy, Folia Med., 53, 44
  5. Abcouwer, 2017, Muller cell-microglia cross talk drives neuroinflammation in diabetic retinopathy, Diabetes, 66, 261, 10.2337/dbi16-0047 · doi:10.2337/dbi16-0047
  6. Wroblewski, 2016, Topical squalamine 0.2% and intravitreal ranibizumab 0.5 mg as combination therapy for macular edema due to branch and central retinal vein occlusion: An open-label, randomized study, Ophthalmic Surg. Lasers Imag. Retina, 47, 914, 10.3928/23258160-20161004-04 · doi:10.3928/23258160-20161004-04
  7. Pacella, 2016, Management of anterior chamber dislocation of a dexamethasone intravitreal implant: A case report, J. Med. Case Rep., 10, 282, 10.1186/s13256-016-1077-2 · doi:10.1186/s13256-016-1077-2
  8. Arnarsson, 2000, Laser treatment and the mechanism of edema reduction in branch retinal vein occlusion, Investig. Ophthalmol. Vis. Sci., 41, 877
  9. Ogata, 2001, Upregulation of pigment epithelium-derived factor after laser photocoagulation, Am. J. Ophthalmol., 132, 427, 10.1016/S0002-9394(01)01021-2 · doi:10.1016/s0002-9394(01)01021-2
  10. Vujosevic, 2013, Subthreshold laser therapy for diabetic macular edema: Metabolic and safety issues, Curr. Med. Chem., 20, 3267, 10.2174/09298673113209990030 · doi:10.2174/09298673113209990030

Cited by

See all 1,358

Metadata

Authors
Wang, W., & Lo, A. C. Y.
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2018-06-20
Volume
19
Issue
6
Pages
1816
ISSN
1422-0067 (ISSN-L)
OpenAlex
W2809489644
Cited by
1,358
References
69
FWCI
64.51
Type
journal article
Language
en
Open access
gold
Funders
  • Health and Medical Research Fund (04150746)
  • The University of Hong Kong Seed Funding Programme for Basic Research (201310159038)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.